| Primary |
| Product Used For Unknown Indication |
50.0% |
| Peptic Ulcer |
25.0% |
| Gastrooesophageal Reflux Disease |
12.5% |
| Prophylaxis |
12.5% |
|
| Hypersensitivity |
25.0% |
| Inappropriate Antidiuretic Hormone Secretion |
25.0% |
| Subacute Cutaneous Lupus Erythematosus |
25.0% |
| White Blood Cell Count Increased |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
49.1% |
| Drug Abuse |
36.0% |
| Hypertension |
3.2% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Dyspepsia |
1.1% |
| Abdominal Discomfort |
0.9% |
| Helicobacter Infection |
0.9% |
| Pulmonary Embolism |
0.8% |
| Asthma |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Gout |
0.6% |
| Non-hodgkin's Lymphoma Recurrent |
0.6% |
| Rheumatoid Arthritis |
0.6% |
| Atrial Fibrillation |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Gastrectomy |
0.5% |
| Infected Skin Ulcer |
0.5% |
| Multiple Myeloma |
0.5% |
| Prophylaxis |
0.5% |
| Rectal Cancer |
0.5% |
|
| Cerebral Haemorrhage |
9.4% |
| Dermatitis Allergic |
9.4% |
| Gastrooesophageal Reflux Disease |
9.4% |
| Hyponatraemia |
9.4% |
| Pituitary Tumour Benign |
6.3% |
| Pseudomembranous Colitis |
6.3% |
| Rheumatoid Arthritis |
6.3% |
| Surgery |
6.3% |
| Agranulocytosis |
3.1% |
| Bone Marrow Failure |
3.1% |
| Death |
3.1% |
| Gastrointestinal Haemorrhage |
3.1% |
| Hypomagnesaemia |
3.1% |
| Leukocytoclastic Vasculitis |
3.1% |
| Light Chain Disease |
3.1% |
| Nausea |
3.1% |
| Skin Atrophy |
3.1% |
| Suicide Attempt |
3.1% |
| Syncope |
3.1% |
| Tetany |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.4% |
| Drug Use For Unknown Indication |
16.2% |
| Hypertension |
9.2% |
| Prophylaxis |
6.6% |
| Rheumatoid Arthritis |
6.4% |
| Pain |
4.8% |
| B-cell Lymphoma |
3.3% |
| Diabetes Mellitus |
2.8% |
| Osteoporosis |
2.6% |
| Depression |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.0% |
| Crohn's Disease |
1.9% |
| Diffuse Large B-cell Lymphoma |
1.9% |
| Non-small Cell Lung Cancer |
1.8% |
| Gastric Disorder |
1.5% |
| Atrial Fibrillation |
1.4% |
| Multiple Myeloma |
1.4% |
| Nausea |
1.2% |
| Breast Cancer |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
|
| Vomiting |
12.8% |
| Renal Failure |
7.6% |
| Weight Decreased |
7.6% |
| Death |
7.0% |
| Pulmonary Embolism |
5.8% |
| Renal Failure Acute |
5.8% |
| Pneumonia |
5.2% |
| Pyrexia |
5.2% |
| Thrombocytopenia |
5.2% |
| Weight Increased |
4.1% |
| Nausea |
3.8% |
| Pleural Effusion |
3.8% |
| Sepsis |
3.8% |
| Syncope |
3.8% |
| Urinary Tract Infection |
3.8% |
| General Physical Health Deterioration |
3.5% |
| Cerebrovascular Accident |
3.2% |
| Somnolence |
2.9% |
| Rheumatoid Arthritis |
2.6% |
| Transaminases Increased |
2.6% |
|
| Interacting |
| Acute Coronary Syndrome |
42.9% |
| Agitation |
10.7% |
| Angina Pectoris |
10.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
10.7% |
| Atrial Fibrillation |
7.1% |
| Burnout Syndrome |
3.6% |
| Depression |
3.6% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Major Depression |
3.6% |
| Pyelonephritis Acute |
3.6% |
|
| Drug Interaction |
25.0% |
| Hepatitis Cholestatic |
25.0% |
| Hyponatraemia |
25.0% |
| Potentiating Drug Interaction |
12.5% |
| Respiratory Rate Increased |
12.5% |
|
